Literature DB >> 19672143

Biology of charged particles.

Eleanor A Blakely1, Polly Y Chang.   

Abstract

Charged particles have moved from the physics laboratory to the clinic because of their advantageous dose profile and biologic effects. This brief review will summarize the basic phenomenological laboratory data that led to the successful clinical use of these modalities in selected tumor sites, and the emerging new genomic and proteomic research that have provided translational evidence for potential molecular mechanisms underlying some impressive clinical results.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19672143     DOI: 10.1097/PPO.0b013e3181b666c5

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  9 in total

1.  Three cases of retroperitoneal sarcoma in which bioabsorbable spacers (bioabsorbable polyglycolic acid spacers) were inserted prior to carbon ion radiotherapy.

Authors:  Itsuko Serizawa; Yohsuke Kusano; Kio Kano; Satoshi Shima; Keisuke Tsuchida; Yosuke Takakusagi; Nobutaka Mizoguchi; Tadashi Kamada; Daisaku Yoshida; Hiroyuki Katoh
Journal:  J Radiat Res       Date:  2022-03-17       Impact factor: 2.724

Review 2.  National Effort to Re-Establish Heavy Ion Cancer Therapy in the United States.

Authors:  Arnold Pompos; Robert L Foote; Albert C Koong; Quynh Thu Le; Radhe Mohan; Harald Paganetti; Hak Choy
Journal:  Front Oncol       Date:  2022-06-14       Impact factor: 5.738

3.  Use of the NASA Space Radiation Laboratory at Brookhaven National Laboratory to Conduct Charged Particle Radiobiology Studies Relevant to Ion Therapy.

Authors:  Kathryn D Held; Eleanor A Blakely; Michael D Story; Derek I Lowenstein
Journal:  Radiat Res       Date:  2016-05-19       Impact factor: 2.841

Review 4.  New physical approaches to treat cancer stem cells: a review.

Authors:  H Ghaffari; J Beik; A Talebi; S R Mahdavi; H Abdollahi
Journal:  Clin Transl Oncol       Date:  2018-06-04       Impact factor: 3.405

5.  Combination of suberoylanilide hydroxamic acid with heavy ion therapy shows promising effects in infantile sarcoma cell lines.

Authors:  Susanne Oertel; Markus Thiemann; Karsten Richter; Klaus J Weber; Peter E Huber; Ramon Lopez Perez; Stephan Brons; Marc Bischof; Andreas E Kulozik; Volker Ehemann; Jürgen Debus; Claudia Blattmann
Journal:  Radiat Oncol       Date:  2011-09-20       Impact factor: 3.481

6.  Three dimensional approach to investigating biological effects along energetic ion beam pathways.

Authors:  Xinglin Li; Shuguang Sun; Shanying Wang; Wenjian Li; Ying Qu; Weidong Cui; Tianren Sun; Jian Zhang; Jufang Wang; Guangming Zhou; Shuli Man; Yi Chen; Fuping Lu; Zengquan Wei; Genming Jin
Journal:  Sci Rep       Date:  2017-03-15       Impact factor: 4.379

Review 7.  Evolution of Carbon Ion Radiotherapy at the National Institute of Radiological Sciences in Japan.

Authors:  Osama Mohamad; Hirokazu Makishima; Tadashi Kamada
Journal:  Cancers (Basel)       Date:  2018-03-06       Impact factor: 6.639

8.  Carbon ion radiotherapy for inoperable pediatric osteosarcoma.

Authors:  Osama Mohamad; Reiko Imai; Tadashi Kamada; Yuki Nitta; Nobuhito Araki
Journal:  Oncotarget       Date:  2018-05-01

Review 9.  The 20th Gray lecture 2019: health and heavy ions.

Authors:  Eleanor A Blakely
Journal:  Br J Radiol       Date:  2020-10-06       Impact factor: 3.039

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.